Global Endoparasiticide 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR122406707

Publication Date:

December 16, 2024

Pages:

108

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Endoparasiticide market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Thereport includes an overview of the development of the Endoparasiticide industry chain, the market status of Veterinary Hospitals or Clinics (Ear Tags, Tablets), Animal Farms (Ear Tags, Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Endoparasiticide.
Regionally, the report analyzes the Endoparasiticide markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Endoparasiticide market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Endoparasiticide market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Endoparasiticide industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ear Tags, Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Endoparasiticide market.
Regional Analysis: The report involves examining the Endoparasiticide market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Endoparasiticide market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Endoparasiticide:
Company Analysis: Report covers individual Endoparasiticide manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Endoparasiticide This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Veterinary Hospitals or Clinics, Animal Farms).
Technology Analysis: Report covers specific technologies relevant to Endoparasiticide. It assesses the current state, advancements, and potential future developments in Endoparasiticide areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Endoparasiticide market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Endoparasiticide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Ear Tags
Tablets
Injectables
Feed Additives
麻豆原创 segment by Application
Veterinary Hospitals or Clinics
Animal Farms
麻豆原创 Care Settings
Major players covered
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoparasiticide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Endoparasiticide, with price, sales, revenue and global market share of Endoparasiticide from 2019 to 2024.
Chapter 3, the Endoparasiticide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoparasiticide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Endoparasiticide market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Endoparasiticide.
Chapter 14 and 15, to describe Endoparasiticide sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Endoparasiticide
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Endoparasiticide Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ear Tags
1.3.3 Tablets
1.3.4 Injectables
1.3.5 Feed Additives
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Endoparasiticide Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Veterinary Hospitals or Clinics
1.4.3 Animal Farms
1.4.4 麻豆原创 Care Settings
1.5 Global Endoparasiticide 麻豆原创 Size & Forecast
1.5.1 Global Endoparasiticide Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Endoparasiticide Sales Quantity (2019-2030)
1.5.3 Global Endoparasiticide Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Endoparasiticide Product and Services
2.1.4 Boehringer Ingelheim Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 Elanco
2.2.1 Elanco Details
2.2.2 Elanco Major Business
2.2.3 Elanco Endoparasiticide Product and Services
2.2.4 Elanco Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Elanco Recent Developments/Updates
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Endoparasiticide Product and Services
2.3.4 Zoetis Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Zoetis Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Endoparasiticide Product and Services
2.4.4 Merck Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Endoparasiticide Product and Services
2.5.4 Virbac Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Virbac Recent Developments/Updates
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Endoparasiticide Product and Services
2.6.4 Novartis AG Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Novartis AG Recent Developments/Updates
2.7 Ceva Sante Animlae
2.7.1 Ceva Sante Animlae Details
2.7.2 Ceva Sante Animlae Major Business
2.7.3 Ceva Sante Animlae Endoparasiticide Product and Services
2.7.4 Ceva Sante Animlae Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Ceva Sante Animlae Recent Developments/Updates
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business
2.8.3 Bayer AG Endoparasiticide Product and Services
2.8.4 Bayer AG Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Bayer AG Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Endoparasiticide Product and Services
2.9.4 Eli Lilly Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Vetoquinol
2.10.1 Vetoquinol Details
2.10.2 Vetoquinol Major Business
2.10.3 Vetoquinol Endoparasiticide Product and Services
2.10.4 Vetoquinol Endoparasiticide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Vetoquinol Recent Developments/Updates
3 Competitive Environment: Endoparasiticide by Manufacturer
3.1 Global Endoparasiticide Sales Quantity by Manufacturer (2019-2024)
3.2 Global Endoparasiticide Revenue by Manufacturer (2019-2024)
3.3 Global Endoparasiticide Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Endoparasiticide by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Endoparasiticide Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Endoparasiticide Manufacturer 麻豆原创 Share in 2023
3.5 Endoparasiticide 麻豆原创: Overall Company Footprint Analysis
3.5.1 Endoparasiticide 麻豆原创: Region Footprint
3.5.2 Endoparasiticide 麻豆原创: Company Product Type Footprint
3.5.3 Endoparasiticide 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Endoparasiticide 麻豆原创 Size by Region
4.1.1 Global Endoparasiticide Sales Quantity by Region (2019-2030)
4.1.2 Global Endoparasiticide Consumption Value by Region (2019-2030)
4.1.3 Global Endoparasiticide Average Price by Region (2019-2030)
4.2 North America Endoparasiticide Consumption Value (2019-2030)
4.3 Europe Endoparasiticide Consumption Value (2019-2030)
4.4 Asia-Pacific Endoparasiticide Consumption Value (2019-2030)
4.5 South America Endoparasiticide Consumption Value (2019-2030)
4.6 Middle East and Africa Endoparasiticide Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Endoparasiticide Sales Quantity by Type (2019-2030)
5.2 Global Endoparasiticide Consumption Value by Type (2019-2030)
5.3 Global Endoparasiticide Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Endoparasiticide Sales Quantity by Application (2019-2030)
6.2 Global Endoparasiticide Consumption Value by Application (2019-2030)
6.3 Global Endoparasiticide Average Price by Application (2019-2030)
7 North America
7.1 North America Endoparasiticide Sales Quantity by Type (2019-2030)
7.2 North America Endoparasiticide Sales Quantity by Application (2019-2030)
7.3 North America Endoparasiticide 麻豆原创 Size by Country
7.3.1 North America Endoparasiticide Sales Quantity by Country (2019-2030)
7.3.2 North America Endoparasiticide Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Endoparasiticide Sales Quantity by Type (2019-2030)
8.2 Europe Endoparasiticide Sales Quantity by Application (2019-2030)
8.3 Europe Endoparasiticide 麻豆原创 Size by Country
8.3.1 Europe Endoparasiticide Sales Quantity by Country (2019-2030)
8.3.2 Europe Endoparasiticide Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Endoparasiticide Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Endoparasiticide Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Endoparasiticide 麻豆原创 Size by Region
9.3.1 Asia-Pacific Endoparasiticide Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Endoparasiticide Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Endoparasiticide Sales Quantity by Type (2019-2030)
10.2 South America Endoparasiticide Sales Quantity by Application (2019-2030)
10.3 South America Endoparasiticide 麻豆原创 Size by Country
10.3.1 South America Endoparasiticide Sales Quantity by Country (2019-2030)
10.3.2 South America Endoparasiticide Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Endoparasiticide Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Endoparasiticide Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Endoparasiticide 麻豆原创 Size by Country
11.3.1 Middle East & Africa Endoparasiticide Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Endoparasiticide Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Endoparasiticide 麻豆原创 Drivers
12.2 Endoparasiticide 麻豆原创 Restraints
12.3 Endoparasiticide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Endoparasiticide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Endoparasiticide
13.3 Endoparasiticide Production Process
13.4 Endoparasiticide Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Endoparasiticide Typical Distributors
14.3 Endoparasiticide Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.